查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1513694

脑积水分流器市场：全球产业分析、规模、占有率、成长、趋势、预测，2024-2032

Hydrocephalus Shunts Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032
出版日期: | 出版商: Persistence Market Research | 英文 344 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于全球脑积水分流器市场的综合报告。该报告全面评估了主要市场动态，包括驱动因素、趋势、机会和课题，并提供了有关市场结构的详细见解。

关键见解

  • 脑积水分流器市场规模（2024 年）：3.1549 亿美元
  • 市场预测金额（2032 年）：4.155 亿美元
  • 全球市场成长率（2024-2032 年复合年增长率）：3.5%

脑积水流市场：研究范围

脑积水流术在脑积水的治疗中发挥重要作用，脑积水的特征是脑脊髓液在大脑中过度积聚。脑积水分流术透过促进脑室内多余脑脊髓液的引流来缓解颅内压并防止神经损伤。市场主要提供各种类型的分流器，如脑室腹腔分流器（VP）、脑室腹腔分流器（VPL）和腰腹腔分流器（LP），主要供医院、神经科诊所和专科手术中心使用。

推动市场成长的因素：

全球脑积水流量市场受到多种因素的推动，例如所有年龄层脑积水盛行率的增加、分流技术的进步以提高治疗效果和患者的预后，以及全球医疗保健支出的增加。此外，人们对神经外科干预措施认识的提高和诊断能力的提高也有助于市场扩张。

市场限制因素：

儘管成长前景广阔，但脑积水分流市场面临与分流併发症相关的课题，如感染、闭塞和机械故障，这些併发症需要进行手术修復，并影响患者的预后。一些地区也存在监管障碍和报销限制，为市场进入和扩张造成障碍。

市场机会：

由于分流设计的技术创新、新兴国家医疗基础设施的增加以及微创手术技术的采用增加，脑积水分流市场正在经历巨大的成长机会。医疗设备製造商、医疗保健提供者和研究机构之间的策略合作对于开发和销售下一代分流系统至关重要。

本报告解决的关键问题

  • 推动脑积水流器市场全球成长的关键因素是什么？
  • 哪些类型的分流器和技术在各种医疗机构中越来越受欢迎？
  • 分流材料与设计的进步如何改变竞争格局？
  • 谁是脑积水流动器市场的主要参与者？ 他们保持市场领先地位的策略是什么？
  • 全球脑积水流动市场的新趋势和未来前景是什么？

目录

第 1 章执行摘要

第二章市场概述

  • 市场范围/分类
  • 市场定义/范围/限制

第三章市场背景

  • 市场动态
  • 情境预测
  • 机会图分析
  • 投资可行性矩阵
  • PESTLE 和 Porter 分析
  • 监理状况
  • 依地区划分的母公司市场前景

第四章全球脑积水流器市场分析

  • 2019-2023 年过去的市场规模金额（百万美元）分析
  • 2024-2032 年当前及未来市场规模预测（百万美元）
    • 年成长趋势分析
    • 绝对数量机会分析

第 5 章全球脑积水流器市场分析：依产品

  • 简介/主要发现
  • 2019-2023 年依产品划分的历史市场规模金额（百万美元）分析
  • 2024-2032 年依产品划分的当前和未来市场规模价值（百万美元）分析和预测
    • 脑积水瓣膜
    • 脑积水导管
    • 神经导航系统
    • 其他
  • 年成长趋势分析：依产品分类，2019-2023 年
  • 绝对价值机会分析：依产品分类，2024-2032 年

第 6 章全球脑积水分流器市场分析：依类型

  • 简介/主要发现
  • 2019-2023 年依类型划分的历史市场规模金额（百万美元）分析
  • 2024-2032 年当前和未来市场规模价值（百万美元）分析和预测（依类型）
    • 心室 - 腹膜
    • 心室 - 心房
    • 心室 - 胸膜
  • 年成长趋势分析：依类型划分，2019-2023 年
  • 绝对机会分析：依类型划分，2024-2032 年

第 7 章全球脑积水流器市场分析：依年龄层

  • 简介/主要发现
  • 2019-2023 年依年龄组别划分的历史市场规模分析（百万美元）
  • 2024-2032 年依年龄组别划分的当前和未来市场规模价值（百万美元）的分析和预测
    • 儿童
    • 成人
  • 年成长趋势分析：依年龄组别划分，2019-2023 年
  • 绝对机会分析：依年龄组别划分，2024-2032 年

第 8 章全球脑积水流器市场分析：依最终使用者划分

  • 简介/主要发现
  • 2019-2023 年最终用户历史市场规模金额（百万美元）分析
  • 2024-2032 年最终用户当前和未来市场规模价值（百万美元）分析和预测
    • 医院
    • 门诊手术中心
    • 其他
  • 年成长趋势分析：依最终用户划分，2019-2023 年
  • 绝对价值机会分析：依最终使用者划分，2024-2032 年

第 9 章全球脑积水流量器市场分析：依地区

  • 简介
  • 2019-2023 年依地区历史市场规模分析（百万美元）
  • 2024-2032 年依地区划分的当前市场规模价值（百万美元）分析与预测
    • 北美
    • 拉丁美洲
    • 欧洲
    • 亚太地区
    • 中东/非洲
  • 区域市场吸引力分析

第 10 章北美脑积水分流器市场分析（依国家）

第 11 章拉丁美洲脑积水分流器市场分析（依国家）

第十二章欧洲脑积水分流器市场分析（依国家）

第十三章亚太地区脑积水分流器市场分析（依国家）

第 14 章中东和非洲脑积水分流器市场分析（依国家/地区）

第十五章主要全国脑积水流器市场分析

  • 美国
  • 加拿大
  • 巴西
  • 墨西哥
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 中国
  • 日本
  • 韩国
  • 新加坡
  • 泰国
  • 印尼
  • 澳大利亚
  • 纽西兰
  • 海湾合作委员会国家
  • 南非
  • 以色列

第十六章市场结构分析

  • 竞争对手仪表板
  • 竞争基准
  • 主要公司市占率分析

第十七章竞争分析

  • 衝突详情
    • B. Braun Melsungen AG
    • Sophysa
    • HpBio Proteses Inc.
    • Integra LifeSciences Holdings Corporation
    • KANEKA MEDIX CORPORATION
    • Medtronic
    • Natus Medical Incorporated
    • Spiegelberg GmbH &Co. KG
    • Desu Medical
    • Natus Neuro

第 18 章先决条件与使用的缩写

第十九章研究方法

简介目录
Product Code: PMRREP33225

Persistence Market Research has recently released a comprehensive report on the worldwide market for hydrocephalus shunts. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Hydrocephalus Shunts Market Size (2024E): USD 315.49 million
  • Projected Market Value (2032F): USD 415.50 million
  • Global Market Growth Rate (CAGR 2024 to 2032): 3.5%

Hydrocephalus Shunts Market - Report Scope:

Hydrocephalus shunts play a critical role in the management of hydrocephalus, a condition characterized by excessive accumulation of cerebrospinal fluid within the brain. These shunts facilitate the diversion of excess fluid from the brain's ventricles to another part of the body, thereby alleviating intracranial pressure and preventing neurological damage. The market caters primarily to hospitals, neurology clinics, and specialized surgical centers, offering a variety of shunt types, including ventriculoperitoneal (VP), ventriculopleural (VPL), and lumboperitoneal (LP) shunts.

Market Growth Drivers:

The global hydrocephalus shunts market is driven by several key factors, including increasing prevalence of hydrocephalus across all age groups, advancements in shunt technology enhancing treatment efficacy and patient outcomes, and rising healthcare expenditures globally. Moreover, growing awareness about neurosurgical interventions and improved diagnostic capabilities contribute to market expansion.

Market Restraints:

Despite promising growth prospects, the hydrocephalus shunts market faces challenges related to shunt complications such as infection, blockage, and mechanical failure, which necessitate surgical revisions and impact patient outcomes. Additionally, regulatory hurdles and reimbursement limitations in some regions pose barriers to market entry and expansion.

Market Opportunities:

The hydrocephalus shunts market presents significant growth opportunities driven by technological innovations in shunt design, increasing healthcare infrastructure in emerging economies, and rising adoption of minimally invasive surgical techniques. Strategic collaborations between medical device manufacturers, healthcare providers, and research institutions are crucial for developing next-generation shunt systems and expanding market reach.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the hydrocephalus shunts market globally?
  • Which shunt types and technologies are gaining traction in different healthcare settings?
  • How are advancements in shunt materials and designs reshaping the competitive landscape?
  • Who are the key players contributing to the hydrocephalus shunts market, and what strategies are they employing to maintain market leadership?
  • What are the emerging trends and future prospects in the global hydrocephalus shunts market?

Competitive Intelligence and Business Strategy:

Leading players in the global hydrocephalus shunts market, including Ophysa,KANEKA MEDIX CORP.,Desu Medical, focus on innovation, product differentiation, and strategic alliances to strengthen their market position. These companies invest significantly in research and development to enhance shunt performance, minimize complications, and improve patient quality of life. Collaborations with healthcare providers and advocacy groups support market expansion efforts and promote clinical best practices.

Key Companies Profiled:

  • B. Braun Melsungen AG (CHRISTOPH MIETHKE GMBH & CO. KG),
  • Ophysa
  • HpBio Proteses, inc.
  • Integra LifeSciences Holdings Corporation
  • KANEKA MEDIX CORP.
  • Medtronic Plc
  • Natus Medical Incorporated
  • Spiegelberg GmbH & Co. KG
  • Desu Medical

Key Segments Covered in the Hydrocephalus Shunts Industry Report

Hydrocephalus Shunts Industry by Type

  • Ventriculo-Peritoneal
  • Ventriculo-Atrial
  • Ventriculo-Pleural
  • Lumbo-Peritoneal

Hydrocephalus Shunts Industry by Product

  • Hydrocephalus Valves
  • Hydrocephalus Catheters
  • Neuronavigation Systems

Hydrocephalus Shunts Industry by Age Group

  • Paediatric
  • Adults

Hydrocephalus Shunts Industry by End User

  • Hospitals
  • Ambulatory Surgical Centers

Hydrocephalus Shunts Industry by Region

  • North America Market
  • Europe Market
  • Asia-Pacific Market
  • Middle East & Africa Market
  • South America Market

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Opportunity Map Analysis
  • 3.4. Investment Feasibility Matrix
  • 3.5. PESTLE and Porter's Analysis
  • 3.6. Regulatory Landscape
    • 3.6.1. By Key Regions
    • 3.6.2. By Key Countries
  • 3.7. Regional Parent Market Outlook

4. Global Hydrocephalus Shunts Market Analysis 2019-2023 and Forecast, 2024-2032

  • 4.1. Historical Market Size Value (US$ Mn) Analysis, 2019-2023
  • 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2024-2032
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Hydrocephalus Shunts Market Analysis 2019-2023 and Forecast 2024-2032, By Product

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Mn) Analysis By Product, 2019-2023
  • 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product, 2024-2032
    • 5.3.1. Hydrocephalus Valves
      • 5.3.1.1. Adjustable Pressure Valves
      • 5.3.1.2. Fix Pressure Valves
    • 5.3.2. Hydrocephalus Catheters
    • 5.3.3. Neuronavigation Systems
    • 5.3.4. Others
  • 5.4. Y-o-Y Growth Trend Analysis By Product, 2019-2023
  • 5.5. Absolute $ Opportunity Analysis By Product, 2024-2032

6. Global Hydrocephalus Shunts Market Analysis 2019-2023 and Forecast 2024-2032, By Type

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size Value (US$ Mn) Analysis By Type, 2019-2023
  • 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Type, 2024-2032
    • 6.3.1. Ventriculo - Peritoneal
    • 6.3.2. Ventriculo - Atrial
    • 6.3.3. Ventriculo - Pleural
  • 6.4. Y-o-Y Growth Trend Analysis By Type, 2019-2023
  • 6.5. Absolute $ Opportunity Analysis By Type, 2024-2032

7. Global Hydrocephalus Shunts Market Analysis 2019-2023 and Forecast 2024-2032, By Age Group

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size Value (US$ Mn) Analysis By Age Group , 2019-2023
  • 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Age Group , 2024-2032
    • 7.3.1. Pediatric
    • 7.3.2. Adults
  • 7.4. Y-o-Y Growth Trend Analysis By Age Group , 2019-2023
  • 7.5. Absolute $ Opportunity Analysis By Age Group , 2024-2032

8. Global Hydrocephalus Shunts Market Analysis 2019-2023 and Forecast 2024-2032, By End User

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2019-2023
  • 8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2024-2032
    • 8.3.1. Hospitals
    • 8.3.2. Ambulatory Surgical Centers
    • 8.3.3. Others
  • 8.4. Y-o-Y Growth Trend Analysis By End User, 2019-2023
  • 8.5. Absolute $ Opportunity Analysis By End User, 2024-2032

9. Global Hydrocephalus Shunts Market Analysis 2019-2023 and Forecast 2024-2032, By Region

  • 9.1. Introduction
  • 9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2019-2023
  • 9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2024-2032
    • 9.3.1. North America
    • 9.3.2. Latin America
    • 9.3.3. Europe
    • 9.3.4. Asia Pacific
    • 9.3.5. MEA
  • 9.4. Market Attractiveness Analysis By Region

10. North America Hydrocephalus Shunts Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 10.2.1. By Country
      • 10.2.1.1. U.S.
      • 10.2.1.2. Canada
    • 10.2.2. By Product
    • 10.2.3. By Type
    • 10.2.4. By Age Group
    • 10.2.5. By End User
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By Type
    • 10.3.4. By Age Group
    • 10.3.5. By End User
  • 10.4. Key Takeaways

11. Latin America Hydrocephalus Shunts Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 11.2.1. By Country
      • 11.2.1.1. Brazil
      • 11.2.1.2. Mexico
      • 11.2.1.3. Rest of Latin America
    • 11.2.2. By Product
    • 11.2.3. By Type
    • 11.2.4. By Age Group
    • 11.2.5. By End User
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Product
    • 11.3.3. By Type
    • 11.3.4. By Age Group
    • 11.3.5. By End User
  • 11.4. Key Takeaways

12. Europe Hydrocephalus Shunts Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 12.2.1. By Country
      • 12.2.1.1. Germany
      • 12.2.1.2. U.K.
      • 12.2.1.3. France
      • 12.2.1.4. Spain
      • 12.2.1.5. Italy
      • 12.2.1.6. Rest of Europe
    • 12.2.2. By Product
    • 12.2.3. By Type
    • 12.2.4. By Age Group
    • 12.2.5. By End User
  • 12.3. Market Attractiveness Analysis
    • 12.3.1. By Country
    • 12.3.2. By Product
    • 12.3.3. By Type
    • 12.3.4. By Age Group
    • 12.3.5. By End User
  • 12.4. Key Takeaways

13. Asia Pacific Hydrocephalus Shunts Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 13.2.1. By Country
      • 13.2.1.1. China
      • 13.2.1.2. Japan
      • 13.2.1.3. South Korea
      • 13.2.1.4. Singapore
      • 13.2.1.5. Thailand
      • 13.2.1.6. Indonesia
      • 13.2.1.7. Australia
      • 13.2.1.8. New Zealand
      • 13.2.1.9. Rest of Asia Pacific
    • 13.2.2. By Product
    • 13.2.3. By Type
    • 13.2.4. By Age Group
    • 13.2.5. By End User
  • 13.3. Market Attractiveness Analysis
    • 13.3.1. By Country
    • 13.3.2. By Product
    • 13.3.3. By Type
    • 13.3.4. By Age Group
    • 13.3.5. By End User
  • 13.4. Key Takeaways

14. MEA Hydrocephalus Shunts Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 14.2.1. By Country
      • 14.2.1.1. GCC Countries
      • 14.2.1.2. South Africa
      • 14.2.1.3. Israel
      • 14.2.1.4. Rest of MEA
    • 14.2.2. By Product
    • 14.2.3. By Type
    • 14.2.4. By Age Group
    • 14.2.5. By End User
  • 14.3. Market Attractiveness Analysis
    • 14.3.1. By Country
    • 14.3.2. By Product
    • 14.3.3. By Type
    • 14.3.4. By Age Group
    • 14.3.5. By End User
  • 14.4. Key Takeaways

15. Key Countries Hydrocephalus Shunts Market Analysis

  • 15.1. U.S.
    • 15.1.1. Pricing Analysis
    • 15.1.2. Market Share Analysis, 2024
      • 15.1.2.1. By Product
      • 15.1.2.2. By Type
      • 15.1.2.3. By Age Group
      • 15.1.2.4. By End User
  • 15.2. Canada
    • 15.2.1. Pricing Analysis
    • 15.2.2. Market Share Analysis, 2024
      • 15.2.2.1. By Product
      • 15.2.2.2. By Type
      • 15.2.2.3. By Age Group
      • 15.2.2.4. By End User
  • 15.3. Brazil
    • 15.3.1. Pricing Analysis
    • 15.3.2. Market Share Analysis, 2024
      • 15.3.2.1. By Product
      • 15.3.2.2. By Type
      • 15.3.2.3. By Age Group
      • 15.3.2.4. By End User
  • 15.4. Mexico
    • 15.4.1. Pricing Analysis
    • 15.4.2. Market Share Analysis, 2024
      • 15.4.2.1. By Product
      • 15.4.2.2. By Type
      • 15.4.2.3. By Age Group
      • 15.4.2.4. By End User
  • 15.5. Germany
    • 15.5.1. Pricing Analysis
    • 15.5.2. Market Share Analysis, 2024
      • 15.5.2.1. By Product
      • 15.5.2.2. By Type
      • 15.5.2.3. By Age Group
      • 15.5.2.4. By End User
  • 15.6. U.K.
    • 15.6.1. Pricing Analysis
    • 15.6.2. Market Share Analysis, 2024
      • 15.6.2.1. By Product
      • 15.6.2.2. By Type
      • 15.6.2.3. By Age Group
      • 15.6.2.4. By End User
  • 15.7. France
    • 15.7.1. Pricing Analysis
    • 15.7.2. Market Share Analysis, 2024
      • 15.7.2.1. By Product
      • 15.7.2.2. By Type
      • 15.7.2.3. By Age Group
      • 15.7.2.4. By End User
  • 15.8. Spain
    • 15.8.1. Pricing Analysis
    • 15.8.2. Market Share Analysis, 2024
      • 15.8.2.1. By Product
      • 15.8.2.2. By Type
      • 15.8.2.3. By Age Group
      • 15.8.2.4. By End User
  • 15.9. Italy
    • 15.9.1. Pricing Analysis
    • 15.9.2. Market Share Analysis, 2024
      • 15.9.2.1. By Product
      • 15.9.2.2. By Type
      • 15.9.2.3. By Age Group
      • 15.9.2.4. By End User
  • 15.10. China
    • 15.10.1. Pricing Analysis
    • 15.10.2. Market Share Analysis, 2024
      • 15.10.2.1. By Product
      • 15.10.2.2. By Type
      • 15.10.2.3. By Age Group
      • 15.10.2.4. By End User
  • 15.11. Japan
    • 15.11.1. Pricing Analysis
    • 15.11.2. Market Share Analysis, 2024
      • 15.11.2.1. By Product
      • 15.11.2.2. By Type
      • 15.11.2.3. By Age Group
      • 15.11.2.4. By End User
  • 15.12. South Korea
    • 15.12.1. Pricing Analysis
    • 15.12.2. Market Share Analysis, 2024
      • 15.12.2.1. By Product
      • 15.12.2.2. By Type
      • 15.12.2.3. By Age Group
      • 15.12.2.4. By End User
  • 15.13. Singapore
    • 15.13.1. Pricing Analysis
    • 15.13.2. Market Share Analysis, 2024
      • 15.13.2.1. By Product
      • 15.13.2.2. By Type
      • 15.13.2.3. By Age Group
      • 15.13.2.4. By End User
  • 15.14. Thailand
    • 15.14.1. Pricing Analysis
    • 15.14.2. Market Share Analysis, 2024
      • 15.14.2.1. By Product
      • 15.14.2.2. By Type
      • 15.14.2.3. By Age Group
      • 15.14.2.4. By End User
  • 15.15. Indonesia
    • 15.15.1. Pricing Analysis
    • 15.15.2. Market Share Analysis, 2024
      • 15.15.2.1. By Product
      • 15.15.2.2. By Type
      • 15.15.2.3. By Age Group
      • 15.15.2.4. By End User
  • 15.16. Australia
    • 15.16.1. Pricing Analysis
    • 15.16.2. Market Share Analysis, 2024
      • 15.16.2.1. By Product
      • 15.16.2.2. By Type
      • 15.16.2.3. By Age Group
      • 15.16.2.4. By End User
  • 15.17. New Zealand
    • 15.17.1. Pricing Analysis
    • 15.17.2. Market Share Analysis, 2024
      • 15.17.2.1. By Product
      • 15.17.2.2. By Type
      • 15.17.2.3. By Age Group
      • 15.17.2.4. By End User
  • 15.18. GCC Countries
    • 15.18.1. Pricing Analysis
    • 15.18.2. Market Share Analysis, 2024
      • 15.18.2.1. By Product
      • 15.18.2.2. By Type
      • 15.18.2.3. By Age Group
      • 15.18.2.4. By End User
  • 15.19. South Africa
    • 15.19.1. Pricing Analysis
    • 15.19.2. Market Share Analysis, 2024
      • 15.19.2.1. By Product
      • 15.19.2.2. By Type
      • 15.19.2.3. By Age Group
      • 15.19.2.4. By End User
  • 15.20. Israel
    • 15.20.1. Pricing Analysis
    • 15.20.2. Market Share Analysis, 2024
      • 15.20.2.1. By Product
      • 15.20.2.2. By Type
      • 15.20.2.3. By Age Group
      • 15.20.2.4. By End User

16. Market Structure Analysis

  • 16.1. Competition Dashboard
  • 16.2. Competition Benchmarking
  • 16.3. Market Share Analysis of Top Players
    • 16.3.1. By Regional
    • 16.3.2. By Product
    • 16.3.3. By Type
    • 16.3.4. By Age Group
    • 16.3.5. By End User

17. Competition Analysis

  • 17.1. Competition Deep Dive
    • 17.1.1. B. Braun Melsungen AG
      • 17.1.1.1. Overview
      • 17.1.1.2. Product Portfolio
      • 17.1.1.3. Profitability by Market Segments
      • 17.1.1.4. Sales Footprint
      • 17.1.1.5. Strategy Overview
        • 17.1.1.5.1. Marketing Strategy
    • 17.1.2. Sophysa
      • 17.1.2.1. Overview
      • 17.1.2.2. Product Portfolio
      • 17.1.2.3. Profitability by Market Segments
      • 17.1.2.4. Sales Footprint
      • 17.1.2.5. Strategy Overview
        • 17.1.2.5.1. Marketing Strategy
    • 17.1.3. HpBio Proteses Inc.
      • 17.1.3.1. Overview
      • 17.1.3.2. Product Portfolio
      • 17.1.3.3. Profitability by Market Segments
      • 17.1.3.4. Sales Footprint
      • 17.1.3.5. Strategy Overview
        • 17.1.3.5.1. Marketing Strategy
    • 17.1.4. Integra LifeSciences Holdings Corporation
      • 17.1.4.1. Overview
      • 17.1.4.2. Product Portfolio
      • 17.1.4.3. Profitability by Market Segments
      • 17.1.4.4. Sales Footprint
      • 17.1.4.5. Strategy Overview
        • 17.1.4.5.1. Marketing Strategy
    • 17.1.5. KANEKA MEDIX CORPORATION
      • 17.1.5.1. Overview
      • 17.1.5.2. Product Portfolio
      • 17.1.5.3. Profitability by Market Segments
      • 17.1.5.4. Sales Footprint
      • 17.1.5.5. Strategy Overview
        • 17.1.5.5.1. Marketing Strategy
    • 17.1.6. Medtronic
      • 17.1.6.1. Overview
      • 17.1.6.2. Product Portfolio
      • 17.1.6.3. Profitability by Market Segments
      • 17.1.6.4. Sales Footprint
      • 17.1.6.5. Strategy Overview
        • 17.1.6.5.1. Marketing Strategy
    • 17.1.7. Natus Medical Incorporated
      • 17.1.7.1. Overview
      • 17.1.7.2. Product Portfolio
      • 17.1.7.3. Profitability by Market Segments
      • 17.1.7.4. Sales Footprint
      • 17.1.7.5. Strategy Overview
        • 17.1.7.5.1. Marketing Strategy
    • 17.1.8. Spiegelberg GmbH & Co. KG
      • 17.1.8.1. Overview
      • 17.1.8.2. Product Portfolio
      • 17.1.8.3. Profitability by Market Segments
      • 17.1.8.4. Sales Footprint
      • 17.1.8.5. Strategy Overview
        • 17.1.8.5.1. Marketing Strategy
    • 17.1.9. Desu Medical
      • 17.1.9.1. Overview
      • 17.1.9.2. Product Portfolio
      • 17.1.9.3. Profitability by Market Segments
      • 17.1.9.4. Sales Footprint
      • 17.1.9.5. Strategy Overview
        • 17.1.9.5.1. Marketing Strategy
    • 17.1.10. Natus Neuro
      • 17.1.10.1. Overview
      • 17.1.10.2. Product Portfolio
      • 17.1.10.3. Profitability by Market Segments
      • 17.1.10.4. Sales Footprint
      • 17.1.10.5. Strategy Overview
        • 17.1.10.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology